Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin's disease

Blood

Volumn 92, Issue 7, 1998, Pages 2220-2228

  Carbone, Antonino ^a   Gloghini, Annunziata ^b   Gaidano, Gianluca ^b   Franceschi, Silvia ^b   Capello, Daniela ^b   Drexler, Hans G ^b   Falini, Brunangelo ^b   Dalla Favera, Riccardo ^b  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; B CELL LYMPHOMA; CELL DIFFERENTIATION; CONTROLLED STUDY; HISTOGENESIS; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL;

ANTIGENS, CD40; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; B-LYMPHOCYTES; CD40 LIGAND; CELL DIFFERENTIATION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GERMINAL CENTER; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; PHENOTYPE; PROTEOGLYCANS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-6; REED-STERNBERG CELLS; SYNDECAN-1; SYNDECANS; T-LYMPHOCYTES; TRANSCRIPTION FACTORS; TUMOR STEM CELLS; TUMOR VIRUS INFECTIONS; VIRAL MATRIX PROTEINS;

EID: 0032188997     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink H-K, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
2. Gruss H-J, Pinto A, Duyster J, Poppema S, Herrmann F: Hodgkin's disease: A tumor with disturbed iminunological pathways. Immunol Today 18:156, 1997
3. Stein H, Hummel M, Dürkop H, Foss H-D, Herbst H: Biology of Hodgkin's disease, in Canellos GP, Lister TA, Sklar JL (eds): The Lymphomas. Philadelphia, PA, Saunders, 1998, p 287
4. De Vita VT Jr, Mauch PM, Harris NL: Hodgkin's disease, in De Vita VT Jr, Hellman S, Rosemberg SA (eds): Cancer Principles & Practice of Oncology (ed 5). Philadelphia, PA, Lippincott-Raven, 1997, p 2242
5. Küppers R, Rajewsky K, Zhao M, Simons G, Laumann R, Fischer R, Hansmann M-L: Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci USA 91:10962, 1994
6. Hummel M, Ziemann K, Lammert H, Pileri S, Sabattini E, Stein H: Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells. N Engl J Med 333:901, 1995
7. Kanzler H, Küppers R, Hansmann M-L, Rajewsky K: Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med 184:1495, 1996
8. Marafioti T, Hummel M, Anagnostopoulos I, Foss HD, Falini B, Delsol G, Isaacson PG, Pileri S, Stein H: Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of higly mutated germinal-center B-cells. N Engl J Med 337:453, 1997
9. Ohno T, Stribley JA, Wu G, Hinrichs SH, Weisenburger DD, Chan WC: Clonality in nodular lymphocyte-predominant Hodgkin's disease. N Engl J Med 337:459, 1997
10. Carbone A, Gaidano G, Gloghini A, Larocca LM, Capello D, Canzonieri V, Antinori A, Tirelli U, Falini B, Dalla-Favera R: Differential expression of BCL-6, CD138/syndecan-1, and Epstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Blood 91:747, 1998
11. Ye BH, Lista F, Lo Coco F, Knowles DM, Offit K, Chaganti RSK, Dalla-Favera R: Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 262:747, 1993
12. Cattoretti G, Chang C-C, Cechova K, Zhang J, Ye BH, Falini B, Louie DC, Offit K, Chaganti RSK, Dalla-Favera R: BCL-6 protein is expressed in germinal-center B cells. Blood 86:45, 1995
13. Dent AL, Shaffer AL, Yu X, Allman D, Staudt LM: Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 276:589, 1997
14. Ye BH, Cattoretti G, Shen Q, Zhang J, Hawe N, de Waard R, Leung C, Nouri-Shirazi M, Orazi A, Chaganti RS, Rothman P, Stall AM, Pandolfi PP, Dalla-Favera R: The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nature Genet 16:161, 1997
15. Allman D, Jain A, Dent A, Maile RR, Selvaggi T, Kehry MR, Staudt LM: BCL-6 expression during B-cell activation. Blood 87:5257, 1996
16. Niu H, Ye BH, Dalla-Favera R: Antigen-receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor. Genes Dev 12:1953, 1998
17. Cattoretti G, Zhang J, Cleary AM, Lederman S, Gaidano G, Carbone A, Chaganti RSK, Dalla-Favera R: Downregulation of BCL-6 gene expression by CD40 and EBV latent membrane protein-1 (LMP-1) and its block in lymphoma carrying BCL-6 rearrangements. Blood 90:175a, 1997 (abstr, suppl 1)
18. Bernfield M, Kokenyesi R, Kato M, Hinkes MT, Spring J, Gallo RL, Lose EJ: Biology of the syndecans: A family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol 8:365, 1992
19. Sanderson RD, Lalor P, Bernfield M: B lymphocytes express and lose syndecan at specific stages of differentiation. Cell Regul 1:27, 1989
20. Ridley RC, Xiao H, Hata H, Woodliff J, Epstein J, Sanderson RD: Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen. Blood 81:767, 1993
21. Wijdenes J, Vooijs WC, Clément C, Post J, Morard F, Vita N, Laurent P, Sun R-X, Klein B, Dore J-M: A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1. Br J Haematol 94:318, 1996
22. Mason DY, Banks PM, Chan J, Cleary ML, Delsol G, de Wolf Peeters C, Falini B, Gatter K, Grogan TM, Harris NL, Isaacson PG, Jaffe ES, Knowles DM, Müller-Hermelink K, Pileri S, Ralfkiaer E, Stein H, Warnke R: Nodular lymphocyte predominance Hodgkin's disease. A distinct clinicopathological entity. Am J Surg Pathol 18:526, 1994
23. Lukes RJ, Craver LF, Hall TC, Rappaport H, Ruben P: Report of the nomenclature committee. Cancer Res 26:1311, 1966
24. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KAF, Stein H, Mason DY: Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal antialkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219, 1984
25. Flenghi L, Ye BH, Fizzotti M, Bigerna B, Cattoretti G, Venturi S, Pacini R, Pileri S, Lo Coco F, Pescarmona E, Pelicci P-G, Dalla-Favera R, Falini B: A specific monoclonal antibody (PG-B6) detects expression of the BCL-6 protein in germinal center B cells. Am J Pathol 147:405, 1995
26. Carbone A, Gloghini A, Volpe R: Immunohistochemistry of Hodgkin and non-Hodgkin lymphomas with emphasis on the diagnostic significance of the BNH9 antibody reactivity with anaplastic large cell (CD30 positive) lymphomas. Cancer 70:2691, 1992
27. Pinto A, Gloghini A, Gattei V, Aldinucci D, Zagonel V, Carbone A: Expression of the c-kit receptor in human lymphomas is restricted to Hodgkin's disease and CD30+ anaplastic large cell lymphomas. Blood 83:785, 1994
28. Carbone A, Gaidano G, Gloghini A, Pastore C, Saglio G, Tirelli U, Dalla-Favera R, Falini B: BCL-6 protein expression in AIDS-related non-Hodgkin's lymphomas. Inverse relationship with Epstein-Barr virus-encoded latent membrane protein-1 expression. Am J Pathol 150:155, 1997
29. Drexler HG: Recent results on the biology of Hodgkin and Reed-Sternberg cells. II. Continuous cell lines. Leuk Lymphoma 9:1, 1993
30. Migliazza A, Martinotti S, Chen W, Fusco C, Ye BY, Knowles DM, Offit K, Chaganti RSK, Dalla-Favera R: Frequent somatic hypermutation of the 5′ noncoding region of the BCL6 gene in B-cell lymphoma. Proc Natl Acad Sci USA 92:12520, 1995
31. Gaidano G, Carbone A, Pastore C, Capello D, Migliazza A, Gloghini A, Roncella S, Ferrarini M, Saglio G, Dalla-Favera R: Frequent mutation of the 5′ noncoding region of the BCL-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Blood 89:3755, 1997
32. Gaidano G, Lo Coco F, Ye BH, Shibata D, Levine AM, Knowles DM, Dalla-Favera R: Rearrangements of the BCL-6 gene in acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma: Association with diffuse large-cell subtype. Blood 84:397, 1994
33. Armitage P, Berry G: Statistical Methods in Medical Research, Oxford, UK, Blackwell Scientific Publications, 1987
34. Falini B, Bigerna B, Pasqualucci L, Fizzotti M, Martelli MF, Pileri S, Pinto A, Carbone A, Venturi S, Pacini R, Cattoretti G, Pescarmona E, Lo Coco F, Pelicci P-G, Anagnastopoulos I, Dalla-Favera R, Flenghi L: Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease. Blood 87:465, 1996
35. Gruss H-J, Hirschstein D, Wright B, Ulrich D, Caligiuri MA, Barcos M, Strockbine L, Armitage RJ, Dower SK: Expression and function of CD40 on Hodgkin and Reed-Sternberg cells and the possible relevance for Hodgkin's disease. Blood 84:2305, 1994
36. Kadin ME: Pathology of Hodgkin's disease. Curr Opinion Oncol 6:456, 1994
37. Carbone A, Gloghini A, Gattei V, Aldinucci D, Degan M, De Paoli P, Zagonel V, Pinto A: Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines. Blood 85:780, 1995
38. Carbone A, Gloghini A, Gruss H-J, Pinto A: CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease. Am J Pathol 147:912, 1995
39. Larocca LM, Capello D, Rinelli A, Non S, Antinori A, Gloghini A, Cingolani A, Migliazza A, Saglio G, Camilleri-Broet S, Raphael M, Carbone A, Gaidano G: The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B-cells. Blood 92:1011, 1998
40. Gires O, Zimber-Strobl U, Gonnella R, Ueffing M, Marschall G, Zeidler R, Pich D, Hammer Schmidt W: Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J 16:6131, 1997